Information Library
Results for: Consulting - Product Development & Commercialization - Market Access
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Quintiles Backs Change to Marketing Mix as NHS Reforms Take Hold
Press Release — READING, UK – 30 May, 2012 – Quintiles has released the first in a series of briefing papers looking at how market access strategies can
-
UK Market Access Insight Brief
White Paper — May 30, 2012
Insight Briefing series on Market Access in key European countries -
Cancer Treatments and the Search for Value
White Paper — April 2, 2012
Cancer Treatment and the Search for Value In September 2011, The Economist Intelligence Unit surveyed 399 senior executives from the life sciences industry and payer -
Consulting – Breakthrough Thinking Built on Experience
Brochure — November 23, 2010
Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today. -
Oncology Drug Development and Value-Based Medicine
White Paper — November 5, 2010
This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices. -
Advancing Oncology Care Through Innovative Treatment Approaches
White Paper — September 22, 2010
In this new white paper, Quintiles’ oncology experts Harish Dave and Eric Groves summarize the new findings and promising results presented at the June ASCO 2010 meeting. -
Executive Vision Forum 2010: Convergence of Stakeholders
Presentation — July 9, 2010
A Holistic Approach to Patient Outcomes - Brian Sweet, CPO, WellPoint. Presentation about the convergence of stakeholders. -
Executive Vision Forum 2010: Clinical and Commercial Convergence
Presentation — July 8, 2010
Pasquale Cetera, VP Portfolio Management, Merck, presentation about the convergence of Clinical and Commercial. -
Bridging Cultures
Case Study — May 9, 2010
Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise. -
PharmAsia News Article Reprint
Media Coverage — March 1, 2010
Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.
